CAMV
Concord Asset Management (Virginia)’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Buy |
23,091
+7,532
| +48% | +$349K | 0.16% | 127 |
|
|
2025
Q1 | $755K | Buy |
15,559
+1,022
| +7% | +$49.6K | 0.17% | 104 |
|
|
2024
Q4 | $822K | Buy |
+14,537
| New | +$822K | 0.18% | 88 |
|
|
2024
Q1 | – | Sell |
-25,353
| Closed | -$1.3M | – | 135 |
|
|
2023
Q4 | $1.3M | Buy |
25,353
+9,738
| +62% | +$500K | 0.38% | 60 |
|
|
2023
Q3 | $906K | Buy |
15,615
+2,967
| +23% | +$172K | 0.3% | 54 |
|
|
2023
Q2 | $809K | Buy |
12,648
+2,330
| +23% | +$149K | 0.29% | 49 |
|
|
2023
Q1 | $715K | Buy |
10,318
+6,911
| +203% | +$479K | 0.29% | 45 |
|
|
2022
Q4 | $245K | Buy |
+3,407
| New | +$245K | 0.17% | 48 |
|